Organization and Description of Business (Details Narrative) - $ / shares |
Apr. 16, 2021 |
Sep. 30, 2021 |
|---|---|---|
| Common Stock, par value | $ 0.0001 | |
| Supera Pharmaceuticals Inc [Member] | Asset Purchase Agreement [Member] | ||
| Stock issued during period, shares, acquisitions | 33,937,909 | |
| MyMD Pharmaceuticals (Florida), Inc [Member] | ||
| Common Stock, par value | $ 0.001 | |
| Exchange ratio price per shares | $ 0.7718 | |
| Stockholders' Equity, Reverse Stock Split | 1-for-2 reverse stock split | |
| Stock issued during period, shares, acquisitions | 32,741,622 |
| X | ||||||||||
- Definition Exchange ratio price per shares. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|